Inkeri, Jussi
Tynjälä, Anniina
Forsblom, Carol
Liebkind, Ron
Tatlisumak, Turgut
Thorn, Lena M.
Groop, Per-Henrik http://orcid.org/0000-0003-4055-6954
Shams, Sara
Putaala, Jukka
Martola, Juha
Gordin, Daniel
,
Funding for this research was provided by:
Folkhälsan Research Foundation
Academy of Finland (316664, UAK10121MRI)
Wilhelm and Else Stockmann Foundation
“Liv och Hälsa” Society
Novo Nordisk Foundation (NNF OC0013657)
Sigrid Juselius Foundation
Päivikki and Sakari Sohlberg Foundation
Finnish Foundation for Cardiovascular Research
Governmental research funding
Biomedicum Helsinki Foundation
Medical Society of Finland
Dorothea Olivia, Karl Walter and Jarl Walter Perklén’s Foundation
University of Helsinki
University of Helsinki including Helsinki University Central Hospital
Article History
Received: 27 August 2020
Accepted: 11 January 2021
First Online: 20 March 2021
Compliance with ethical standards
:
: D.G. Lecture or advisory honoraria: AstraZeneca, Boehringer Ingelheim, Delta Medical Communications, Fresenius, GE Healthcare, Novo Nordisk. Support to attend medical meetings: CVRx., Sanofi Aventis. J.M. Lecture Honoria Santen. P.-H.G. has received lecture honoraria from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Elo Water, Genzyme, Medscape, Merck Sharp & Dohme (MSD), Mundipharma, Novartis, Novo Nordisk, PeerVoice, Sanofi, SCIARC and is an advisory board member of AbbVie, Bayer, Boehringer Ingelheim, Eli Lilly, Janssen, Medscape, MSD, Novartis, Novo Nordisk and Sanofi. No other potential conflicts of interest relevant to this article were reported.
: The study was carried out in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the Helsinki and Uusimaa Hospital District.
: Each participant signed a written informed consent before participation.
: Not applicable.